Literature DB >> 17955232

The basal ganglia: a substrate for fatigue in multiple sclerosis.

N Téllez1, J Alonso, J Río, M Tintoré, C Nos, X Montalban, A Rovira.   

Abstract

INTRODUCTION: The origin of fatigue in multiple sclerosis (MS) remains uncertain. However, the use of nonconventional magnetic resonance techniques has increased our understanding of this problem. We aimed to study the relationship between fatigue in MS and the presence of focal dysfunction in the basal ganglia and frontal white matter.
METHODS: Included in the study were 41 patients with relapsing-remitting MS with mild disability and 20 healthy controls. Fatigue was assessed by the Fatigue Severity Scale (FSS) and the Modified Fatigue Impact Scale (MFIS). Patients were classified as "fatigued" when they expressed a subjective feeling of fatigue, and the FSS score was >or=5.0 and/or the MFIS score was >38. Patients with no subjective fatigue were classified as "nonfatigued" when the FSS score was <4.0. Proton magnetic resonance spectra were obtained from two different regions: the frontal white matter and the lentiform nucleus. The relationships between fatigue and NAA/Cr, NAA/Cho and Cho/Cr ratios were analysed.
RESULTS: A significant decrease in NAA/Cr in the lentiform nucleus region in patients with fatigue was observed. No differences between the groups were found in the frontal white matter.
CONCLUSION: Although confirmatory studies are needed, our results would support the idea that a specific dysfunction or involvement of the basal ganglia might partly contribute to the development of MS-related fatigue.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17955232     DOI: 10.1007/s00234-007-0304-3

Source DB:  PubMed          Journal:  Neuroradiology        ISSN: 0028-3940            Impact factor:   2.804


  35 in total

1.  Cerebral grey matter pathology and fatigue in patients with multiple sclerosis: a preliminary study.

Authors:  M Codella; M A Rocca; B Colombo; F Martinelli-Boneschi; G Comi; M Filippi
Journal:  J Neurol Sci       Date:  2002-02-15       Impact factor: 3.181

2.  Fatigue in multiple sclerosis: a comparison of different rating scales and correlation to clinical parameters.

Authors:  P Flachenecker; T Kümpfel; B Kallmann; M Gottschalk; O Grauer; P Rieckmann; C Trenkwalder; K V Toyka
Journal:  Mult Scler       Date:  2002-12       Impact factor: 6.312

3.  Analysis of complications of radiofrequency pallidotomy.

Authors:  Zhang Hua; Gao Guodong; Liang Qinchuan; Zhao Yaqun; Wang Qinfen; Wang Xuelian
Journal:  Neurosurgery       Date:  2003-01       Impact factor: 4.654

4.  Total brain N-acetylaspartate: a new measure of disease load in MS.

Authors:  O Gonen; I Catalaa; J S Babb; Y Ge; L J Mannon; D L Kolson; R I Grossman
Journal:  Neurology       Date:  2000-01-11       Impact factor: 9.910

5.  Fatigue in multiple sclerosis: relationship to depression, disability, and disease pattern.

Authors:  D C Kroencke; S G Lynch; D R Denney
Journal:  Mult Scler       Date:  2000-04       Impact factor: 6.312

6.  Does the Modified Fatigue Impact Scale offer a more comprehensive assessment of fatigue in MS?

Authors:  N Téllez; J Río; M Tintoré; C Nos; I Galán; X Montalban
Journal:  Mult Scler       Date:  2005-04       Impact factor: 6.312

7.  1H NMR chemical shift selective (CHESS) imaging.

Authors:  A Haase; J Frahm; W Hänicke; D Matthaei
Journal:  Phys Med Biol       Date:  1985-04       Impact factor: 3.609

8.  Fatigue and magnetic resonance imaging activity in multiple sclerosis.

Authors:  C Mainero; J Faroni; C Gasperini; M Filippi; E Giugni; O Ciccarelli; M Rovaris; S Bastianello; G Comi; C Pozzilli
Journal:  J Neurol       Date:  1999-06       Impact factor: 4.849

9.  Deep gray matter and fatigue in MS: a T1 relaxation time study.

Authors:  G Niepel; Ch R Tench; P S Morgan; N Evangelou; D P Auer; C S Constantinescu
Journal:  J Neurol       Date:  2006-03-13       Impact factor: 4.849

10.  Thalamic neurodegeneration in relapsing-remitting multiple sclerosis.

Authors:  M Wylezinska; A Cifelli; P Jezzard; J Palace; M Alecci; P M Matthews
Journal:  Neurology       Date:  2003-06-24       Impact factor: 9.910

View more
  34 in total

Review 1.  Fatigue in multiple sclerosis: mechanisms, evaluation, and treatment.

Authors:  Tiffany J Braley; Ronald D Chervin
Journal:  Sleep       Date:  2010-08       Impact factor: 5.849

2.  Functional MRI during the execution of a motor task in patients with multiple sclerosis and fatigue.

Authors:  I Specogna; F Casagrande; A Lorusso; M Catalan; A Gorian; L Zugna; R Longo; M Zorzon; M Naccarato; G Pizzolato; M Ukmar; M A Cova
Journal:  Radiol Med       Date:  2012-06-22       Impact factor: 3.469

Review 3.  CCSVI and MS: no meaning, no fact.

Authors:  Claudio Baracchini; Matteo Atzori; Paolo Gallo
Journal:  Neurol Sci       Date:  2012-05-09       Impact factor: 3.307

4.  Effect of eszopiclone on sleep disturbances and daytime fatigue in multiple sclerosis patients.

Authors:  Hrayr Attarian; Garrick Applebee; Angela Applebee; Bingxia Wang; Melissa Clark; Becky McCormick; Emma Salzman; Catherine Schuman
Journal:  Int J MS Care       Date:  2011

Review 5.  Cancer-related and treatment-related fatigue.

Authors:  Xin Shelley Wang; Jeanie F Woodruff
Journal:  Gynecol Oncol       Date:  2014-10-23       Impact factor: 5.482

6.  Cognitive fatigue defined in the context of attention networks.

Authors:  Roee Holtzer; Melissa Shuman; Jeannette R Mahoney; Richard Lipton; Joe Verghese
Journal:  Neuropsychol Dev Cogn B Aging Neuropsychol Cogn       Date:  2010-10-10

7.  Biological outcome measurements for behavioral interventions in multiple sclerosis.

Authors:  Anja Fischer; Christoph Heesen; Stefan M Gold
Journal:  Ther Adv Neurol Disord       Date:  2011-07       Impact factor: 6.570

Review 8.  4-Aminopyridine for symptomatic treatment of multiple sclerosis: a systematic review.

Authors:  Henrik Boye Jensen; Mads Ravnborg; Ulrik Dalgas; Egon Stenager
Journal:  Ther Adv Neurol Disord       Date:  2014-03       Impact factor: 6.570

9.  Effort-related motivational effects of the pro-inflammatory cytokine interleukin-6: pharmacological and neurochemical characterization.

Authors:  Samantha E Yohn; Yumna Arif; Allison Haley; Guiseppe Tripodi; Younis Baqi; Christa E Müller; Noemi San Miguel; Mercè Correa; John D Salamone
Journal:  Psychopharmacology (Berl)       Date:  2016-08-06       Impact factor: 4.530

Review 10.  Activational and effort-related aspects of motivation: neural mechanisms and implications for psychopathology.

Authors:  John D Salamone; Samantha E Yohn; Laura López-Cruz; Noemí San Miguel; Mercè Correa
Journal:  Brain       Date:  2016-05       Impact factor: 13.501

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.